BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 6471209)

  • 1. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mucosal biopsies and postoperative urinary cytology in patients with bladder cancer.
    Gil-Salom M; Sánchez MC; Chuan P; Clar F; Santamaría J; García-Sisamón F
    Eur Urol; 1990; 17(4):281-5. PubMed ID: 2364965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine cytology in bladder tumors.
    Zein TA; Milad MF
    Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of bladder cancer with cytology and biopsy.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    Br J Urol; 1978 Dec; 50(7):496-501. PubMed ID: 572723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers.
    Denis L; Nowé P; Declercq G
    Eur Urol; 1980; 6(3):137-8. PubMed ID: 7371657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ?
    Haase RN; Harving N
    Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy.
    Iinuma K; Yuhara K; Kotaka H; Ozawa K; Kato D; Takai M; Nakane K; Mizutani K; Tsuchiya T; Koie T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1321. PubMed ID: 33174397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
    Trott PA; Edwards L
    J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.
    Lotan Y; Roehrborn CG
    Urology; 2003 Jan; 61(1):109-18; discussion 118. PubMed ID: 12559279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of dysplasia associated with bladder cancer--histopathological findings of bladder giant sections and related urinary cytology].
    Sekine H
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):545-54. PubMed ID: 2747096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of urine cytology in the assessment of lower urinary tract symptoms.
    Potter JM; Quigley M; Pengelly AW; Fawcett DP; Malone PR
    BJU Int; 1999 Jul; 84(1):30-1. PubMed ID: 10444120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?
    Keller AK; Jensen JB
    Scand J Urol; 2017 Aug; 51(4):290-292. PubMed ID: 28398114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of carcinoma in situ and dysplasia in association with bladder cancer.
    Kakizoe T; Matumoto K; Nishio Y; Ohtani M; Kishi K
    J Urol; 1985 Mar; 133(3):395-8. PubMed ID: 3973990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
    Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
    J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?
    Morrison DA; Murphy WM; Ford KS; Soloway MS
    J Urol; 1984 Oct; 132(4):672-4. PubMed ID: 6471210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis.
    Wijkström H; Lundh B; Tribukait B
    Scand J Urol Nephrol; 1987; 21(2):119-23. PubMed ID: 3616503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.